Abstract
We have investigated the mechanism of resistance to adriamycin (ADR) of 3 human glioma cell lines in culture. The cell lines had different inherent sensitivities to ADR. Verapamil increased the ADR sensitivities of the 2 most resistant cell lines (G-UVW and G-CCM) by up to 5-fold. This effect was not seen in a sensitive cell line (G-MCF). Although the accumulation of ADR in the 3 cell lines was not related to inherent sensitivity, energy deprivation or the addition of verapamil produced an increase (up to 46%) in net uptake for both G-UVW and G-CCM, but not for G-MCF. For G-UVW the ADR efflux data were consistent with an energy-dependent ADR efflux mechanism which could be inhibited by verapamil. A similar mechanism was not found for G-CCM. In this cell line verapamil may act by increasing intracellular ADR binding. These data indicate that, while inherent resistance to ADR may be multifactorial, one possible mechanism of resistance in human glioma may involve changes in drug accumulation and/or binding as has been seen in animals models. A potential clinical role for verapamil in overcoming drug resistance in human solid tumours is also indicated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Merry, S., Fetherston, C., Kaye, S. et al. Resistance of human glioma to adriamycin in vitro: The role of membrane transport and its circumvention with verapamil. Br J Cancer 53, 129–135 (1986). https://doi.org/10.1038/bjc.1986.18
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.18
This article is cited by
-
Design, Development, In Silico, and In Vitro Characterization of Camptothecin-Loaded Mixed Micelles: In Vitro Testing of Verapamil and Ranolazine for Repurposing as Coadjuvant Therapy in Cancer
Journal of Pharmaceutical Innovation (2023)
-
Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma
Cancer Chemotherapy and Pharmacology (1994)
-
Human cell lines as models for multidrug resistance in solid tumours
Cytotechnology (1993)
-
Verapamil and cyclosporin a sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration
Bioscience Reports (1990)
-
Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia
Journal of Cancer Research and Clinical Oncology (1987)